CLINICAL_TRIALS
trial_result
· 2011-08-17
Clinical Trial Update: Dose Ranging Study for Indacaterol in Japanese Asthma Patients [Phase 2]
Summary
Phase 2 dose-ranging trial of indacaterol in Japanese asthma patients has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2011-08-17